Journal of Clinical Endocrinology & Metabolism, Vol 80, 965-970, Copyright © 1995 by Endocrine Society

ARTICLES

Expression and modulation of the parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in skin fibroblasts from patients with type Ib pseudohypoparathyroidism

F Suarez, JJ Lebrun, D Lecossier, B Escoubet, C Coureau and C Silve
CNRS URA583, Hopital Necker Enfants Malades, Faculte de Medecine, Paris, France.

To explore the possibility that defects in the regulation of expression of the messenger ribonucleic acid (mRNA) coding for the PTH receptor could be involved in pseudohypoparathyroidism type Ib (PHP-Ib), PTH- induced cAMP production and PTH/PTH-related peptide (PTH-rp) receptor mRNA expression, measured using a ribonuclease protection assay, were compared in untreated and dexamethasone (dexa)-pretreated (5 x 10(-7) mol/L; 7 days) cultured skin fibroblasts from controls (n = 4) and patients with PHP-Ib (n = 6). In control fibroblasts, stimulation of cAMP production by PTH and expression of PTH/PTH-rp receptor mRNA were easily detectable and were not significantly affected by dexa pretreatment. In fibroblasts from three PHP-Ib patients demonstrating reduced PTH-induced cAMP production that was reversed by dexa, the level of basal PTH/PTH-rp receptor mRNA was also reduced, but increased to levels similar to those in control cells after dexa pretreatment. In fibroblasts from a patient with resistance to PTH not reversed by dexa, PTH/PTH-rp receptor mRNA expression was also significantly lower than that in control cells (18 +/- 13%; P < 0.001) and remained only 30 +/- 15% of that observed in control cells after dexa pretreatment (P < 0.001). In fibroblasts from two PHP-Ib patients expressing normal cAMP responsiveness to PTH before and after dexa treatment, the level of PTH/PTH-rp receptor mRNA was not different from that in control cells before or after dexa treatment. Thus, in all conditions where PTH- induced cAMP production by PHP-Ib fibroblasts was reduced, the abnormality could be explained by the reduced level of PTH/PTH-rp receptor mRNA in these cells. These results suggest that defects in the regulation of expression of the PTH/PTH-rp receptor mRNA, not structural defects in the receptor itself, explain the PTH resistance in PHP-Ib in the patients evaluated, but several different defects must exist.

This article has been cited by other articles:

				L. F. Frohlich, M. Bastepe, D. Ozturk, H. Abu-Zahra, and H. Juppner Lack of Gnas Epigenetic Changes and Pseudohypoparathyroidism Type Ib in Mice with Targeted Disruption of Syntaxin-16 Endocrinology, June 1, 2007; 148(6): 2925 - 2935. [Abstract] [Full Text] [PDF]

				T. Uchida, F. Rossignol, M. A. Matthay, R. Mounier, S. Couette, E. Clottes, and C. Clerici Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1{alpha} and HIF-2{alpha} Expression in Lung Epithelial Cells: IMPLICATION OF NATURAL ANTISENSE HIF-1{alpha} J. Biol. Chem., April 9, 2004; 279(15): 14871 - 14878. [Abstract] [Full Text] [PDF]

				M. Minagawa, T. Watanabe, Y. Kohno, H. Mochizuki, G. N. Hendy, D. Goltzman, J. H. White, and T. Yasuda Analysis of the P3 Promoter of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene in Pseudohypoparathyroidism Type 1b J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1394 - 1397. [Abstract] [Full Text]

				S. M. Jan de Beur, C.-L. Ding, M. C. LaBuda, T. B. Usdin, and M. A. Levine Pseudohypoparathyroidism 1b: Exclusion of Parathyroid Hormone and Its Receptors as Candidate Disease Genes J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2239 - 2246. [Abstract] [Full Text]

				M. Mannstadt, H. Juppner, and T. J. Gardella Receptors for PTH and PTHrP: their biological importance and functional properties Am J Physiol Renal Physiol, November 1, 1999; 277(5): F665 - F675. [Abstract] [Full Text] [PDF]

				M. Karperien, H. J. van der Harten, R. van Schooten, H. Farih-Sips, N. S. den Hollander, S. L. J. Kneppers, P. Nijweide, S. E. Papapoulos, and C. W. G. M. Lowik A Frame-Shift Mutation in the Type I Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Causing Blomstrand Lethal Osteochondrodysplasia J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3713 - 3720. [Abstract] [Full Text] [PDF]

				H. Juppner, E. Schipani, M. Bastepe, D. E. C. Cole, M. L. Lawson, M. Mannstadt, G. N. Hendy, H. Plotkin, H. Koshiyama, T. Koh, et al. The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3 PNAS, September 29, 1998; 95(20): 11798 - 11803. [Abstract] [Full Text] [PDF]

				J. A. Fischer, F. Egert, E. Werder, and W. Born An Inherited Mutation Associated with Functional Deficiency of the {alpha}-Subunit of the Guanine Nucleotide-Binding Protein Gs in Pseudo- and Pseudopseudohypoparathyroidism J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 935 - 938. [Abstract] [Full Text]

				J. D. Bettoun, M. Minagawa, M. Y. Kwan, H. S. Lee, T. Yasuda, G. N. Hendy, D. Goltzman, and J. H. White Cloning and Characterization of the Promoter Regions of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene: Analysis of Deoxyribonucleic Acid from Normal Subjects and Patients with Pseudohypoparathyroidism Type 1b J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1031 - 1040. [Abstract] [Full Text] [PDF]